LumiMeds

Provider Profile Name: LumiMeds
Website: lumimeds.com
Founded: 2023
Provider Type: Telehealth — Virtual Only, Direct-to-Consumer

Operating Details

• Fully virtual — online intake form, telehealth consultation (video or phone depending on state), home delivery
• LegitScript certified
• All treatments sourced from 503A/503B compounding pharmacies
• No membership required; no insurance required; HSA/FSA accepted
• Ships to most US states; state laws on compounded medication shipping may limit availability in some locations
• No lifestyle coaching, no bundled lab work, no long-term commitment required
• One of the few telehealth companies that discloses the compounding pharmacy used on the product page
• FDA warning letter received September 9, 2025 (see below)
• No named medical director publicly disclosed

Approach LumiMeds was founded in 2023 to make GLP-1 weight loss medication more accessible through affordable compounded options, promoting a friendly, no-surprises model that keeps pricing simple and care personalized, with a focus on convenience and value without the upsells or ongoing fees found with larger competitors.

About the Company

LumiMeds has earned strong word-of-mouth for its pricing, fast fulfillment, and patient-focused service, operating in many states through telemedicine and working with licensed US compounding pharmacies to ship directly to patients.

A meaningful transparency point: LumiMeds is one of the few telehealth companies that discloses the compounding pharmacy it uses directly on the product page — allowing patients to independently verify the pharmacy’s licensure and regulatory status before ordering, a practice uncommon in the broader compounded GLP-1 telehealth market.

FDA Warning Letter — September 9, 2025

GLP-1 Weight Loss

• Lose pounds of fat every week
• Money Back Guarantee
• No membership or hidden fees! Everything you need is included
• Start for just $179, no insurance required + free shipping

GLP-1 for Just $179

100k MembersHSA/FSA ApprovedFrom $179

On September 9, 2025, the FDA issued a warning letter citing LumiMeds’ marketing claims for compounded GLP-1s as misleading — the same date a broader batch of approximately 55 warning letters was issued to telehealth platforms across the GLP-1 space, including Hims & Hers. The violation category was consistent with the broader industry enforcement action: marketing language implying FDA approval or equivalence for compounded products that have not been through FDA review. LumiMeds’ website now carries explicit disclaimers that compounded medications are not FDA-approved and have not been evaluated for safety, effectiveness, or quality.

GLP-1 Offerings and Weight Loss Services

LumiMeds offers compounded semaglutide and tirzepatide, with no brand-name medication options:

Compounded Semaglutide (GLP-1):

• Monthly subscription and 3-month prepaid plans
• Program includes initial telehealth visit, real-time physician support, prescription and medication, and remote monthly check-ins

Compounded Tirzepatide (GLP-1/GIP):

• Monthly, 3-month value, and 3-month starter plan options
• Same program inclusions as semaglutide

Additional Treatments:

• NAD+ injections — starting at $89/month introductory, then $249/month

No lifestyle coaching, app-based tracking, or nutrition guidance is included. There is no coaching, no bundled lab work, and no long-term commitment — for patients who want to manage their own weight loss plan while still having access to a licensed provider, LumiMeds strikes the right balance.

Pricing — and What Reviewers Say

Semaglutide is offered at $189 per month on a standard subscription or $133 per month when you prepay a three-month block. Tirzepatide is $279 per month monthly, $216 per month on the three-month value plan, and $133 per month on the three-month starter plan.

Pricing stays fixed even as your dose changes — a flat-dose model similar to Ivy Rx’s approach, which eliminates the cost escalation patients often encounter on titration-priced platforms.

Key policy notes:

• $60 cancellation fee applies before pharmacy submission; no refunds after the pharmacy receives the order; 28-day advance notice required for subscription cancellations
• Risk of loss passes to the carrier once shipped; shipping issues must be reported within 48 hours

What reviewers say about pricing: Pricing is posted clearly on the website with no hidden fees, and patients consistently cite affordability and pricing transparency as the platform’s primary draw. One area of noted confusion: the products page lists both monthly plans and multi-month subscription options at differing prices in ways that are not always clear to new users, making it difficult to immediately understand exactly what is included in each plan before signing up. Patients should review plan terms carefully before selecting.

Reviews from Trustpilot and Google

LumiMeds has 551 Trustpilot reviews at time of writing — a meaningful pool that provides solid independent signal.

What patients praise:

• Customer support is the dominant positive theme — patients frequently mention individual staff members by name, praising attentiveness, clear communication, and a personal rather than automated support feel
• Fast approval and medication delivery, with most patients reporting straightforward ordering and timely fulfillment
• The no-membership, no-hidden-fees model is consistently appreciated

Common complaints:

• A recurring complaint involves compounded tirzepatide perceived as weak or ineffective compared to other providers or prior brand-name use — multiple reviewers describe the product as appearing diluted or failing to produce appetite suppression
• At least one reviewer reports receiving tirzepatide from a different pharmacy than their first month, at a different concentration, without advance disclosure — consistent with the supply chain variability issue noted across multiple platforms in this review series
• The strict refund policy (no refunds after pharmacy receives the order) is noted as a risk for patients who find the medication ineffective

Compounding Pharmacies Used

LumiMeds sources all treatments from 503A/503B compounding pharmacies and is one of the few platforms in this series that discloses specific pharmacy partners directly on product pages. Patients can verify the disclosed pharmacy’s licensure and accreditation status independently — a meaningful transparency advantage. However, reviewer accounts suggest that the fulfilling pharmacy may change between orders, which patients should watch for and ask about proactively.

Note: LumiMeds received an FDA warning letter on September 9, 2025 for misleading marketing claims about compounded GLP-1 products — part of a broader industry enforcement action that same day. The website now carries appropriate disclaimers. The platform’s transparent pricing, LegitScript certification, 503A/503B pharmacy sourcing, and pharmacy name disclosure on product pages are meaningful positive signals. The strict refund policy (no refunds after pharmacy receives the order) and a recurring Trustpilot complaint about tirzepatide potency variability are worth weighing before committing to a prepaid plan. Compounded medications are not FDA-approved. Always consult a licensed medical provider before beginning any GLP-1 program.